Clinical studies investigating the effect of vitamin E therapy in patients with NASH

Watch a video presentation of this article Nonalcoholic steatohepatitis (NASH) is the inflammatory sequelae of fatty liver disease that is characterized histologically by steatosis with ballooning degeneration and lobular hepatitis. NASH and particularly fibrosis development are significantly associated with increased all-cause and liver-related mortality.1, 2 By 2030, NASH is projected to affect more than 27 million patients in the United...